**Executive Summary**
This document, released on February 13, 2026, by PIB Delhi, concerns the regulated pricing of coronary stents (Bare Metal Stents (BMS) and Drug Eluting Stents (DES)) under the Drugs (Prices Control) Order, 2013 (DPCO, 2013). It outlines current ceiling prices, manufacturer and hospital requirements for transparency in billing, and the role of state governments in controlling excessive pricing. The information was provided by the Union Minister of State for Chemicals and Fertilizers in a written reply in the Lok Sabha.
**Key Points / Main Content**
* **Price Controls and Applicability:**
* Coronary stents (BMS and DES) are included in Schedule-I of DPCO, 2013.
* NPPA fixes ceiling prices: ₹10,692.69 for BMS and ₹38,933.14 for DES.
* Prices are applicable across the country.
* **Manufacturer and Importer Obligations:**
* Manufacturers, marketers, and importers must sell stents within the ceiling price plus GST.
* **Hospital Billing Transparency:**
* Institutions performing angioplasty must comply with ceiling prices.
* They must specifically and separately mention stent details in billing: category (BMS/DES), brand name, manufacturer/importer, batch number, specifications.
* **State Government Role:**
* States are responsible for taking action against excessive charges by private hospitals.
* **Clinical Establishments Act (CE Act):**
* CE Act (2010) and Rules (2012) regulate government and private clinical establishments.
* State Governments and Union Territories are primarily responsible for regulating their hospitals.
* Clinical establishments must meet minimum standards of facilities and services and display rates conspicuously.
* The CE Act empowers district-level authorities to take action for violations.
**Impact Analysis**
**Manufacturers, Marketers and Importers of Stents:**
* **Impact:** These entities must adhere to the ceiling prices set by NPPA.
* **Action Required:** Sell their products within the regulated ceiling price (plus applicable GST).
**Hospitals, Nursing Homes, and Clinics Performing Angioplasty:**
* **Impact:** These institutions must comply with the ceiling prices for coronary stents when billing patients directly.
* **Action Required:** Disclose stent details (category, brand, manufacturer, batch number, specifications) separately in invoices and comply with ceiling prices.
**State Governments / Union Territory Administrations:**
* **Impact:** Responsible for regulating hospitals within their jurisdiction to ensure affordable and quality healthcare.
* **Action Required:** Take cognizance of cases of excessive charging and take appropriate action to prevent and control such practices. Ensure hospitals comply with the CE Act and display rates.
**Patients:**
* **Impact:** Affected by the pricing of coronary stents and the transparency of billing practices.
* **Action Required:** Be aware of the ceiling prices and ensure that hospitals comply with the disclosure requirements for stent costs.
**District Collectors / District Magistrates:**
* **Impact:** Empowered under the CE Act to take actions against violations within their district.
* **Action Required:** Enforce the provisions of the CE Act, including imposing penalties for violations.
Key Entities Referenced
Drugs (Prices Control) Order, 2013 (DPCO, 2013): Order that includes coronary stents in Schedule-I, allowing NPPA to fix ceiling prices.
National Pharmaceutical Pricing Authority (NPPA): Regulator responsible for fixing the ceiling prices of coronary stents under the DPCO, 2013.
The Clinical Establishments (Registration and Regulation) Act, 2010 (CE Act): Act providing for registration and regulation of clinical establishments, impacting the provision of healthcare, including rates charged to patients.
Ministry of Chemicals and Fertilizers: Union Ministry providing information related to pricing policies in chemical and fertilizer related matters.
Ministry of Chemicals and Fertilizers
Increase in the Price of Cardiac Stents
Posted On: 13 FEB 2026 5:18PM by PIB Delhi
Coronary stents [Bare Metal Stents (BMS) and Drug Eluting Stents (DES)] are included in Schedule-I of
the Drugs (Prices Control) Order, 2013 (DPCO, 2013) and accordingly NPPA fixes their ceiling prices as
per the provisions of DPCO, 2013. The present applicable ceiling price for BMS is ₹10,692.69 and for
DES ₹38,933.14. The prices fixed under DPCO, 2013 are applicable across the country. All
manufacturers, marketers and importers of stents are required to sell their products within such ceiling
price (plus applicable Goods and Service Tax). Also, NPPA issued a notification dated 12.2.2018,
requiring that institutions such as hospitals, nursing homes and clinics performing angioplasty procedures
using coronary stents who bill patients directly shall comply with the ceiling prices notified in the
notification. Further, the said notification also requires such institutions to specifically and separately
mention in their estimate / proforma invoice / final billing, etc. the cost of the coronary stents, its category
like bare-metal stent (BMS) or drug-eluting stent (DES), brand name, name of the manufacturer / importer
/ batch number / specifications and other details.
Further, as per constitutional provisions, ‘Health’ is a State subject. It is the responsibility of respective
State Government / Union Territory Administration to take cognizance of cases of excessive amounts
being charged by private hospitals and take action to prevent and control such practices. However, the
Government of India, enacted ‘The Clinical Establishments (Registration and Regulation) Act, 2010’ (CE
Act) and notified ‘The Clinical Establishments (Central Government) Rules, 2012’ thereunder to provide
for registration and regulation of Government as well as private clinical establishments belonging to
recognized systems of medicine i.e. Allopathy, Yoga, Naturopathy, Ayurveda, Homoeopathy, Siddha and
Unani System of medicines, or any other system of medicine as may be recognised by the Central
Government (except those of Armed Forces). The State Governments and Union Territories
Administration which have adopted the CE Act are primarily responsible for regulating their hospitals
including private hospitals as per provisions of the CE Act and Rules thereunder to ensure the provision of
affordable and quality healthcare to patients. As per the CE Act, all the clinical establishments
(Government & private) are required to fulfil the conditions of minimum standards of facilities and
services and inter-alia, display of rates charged by them at a conspicuous place. The CE Act has
empowered a registering authority at the District level under the chairmanship of the District Collector /
District Magistrate to take actions including imposing penalties in respect of violation of its provisions.
This information was given by Union Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel,
in a written reply in the Lok Sabha today.
*****
GS/PM
(Release ID: 2227619) Visitor Counter : 98
Read this release in: Urdu